1
Chemicals for use in science; chemicals for use in biotechnology and chemicals produced through biotechnological processes; peptides and polypeptides; including the aforesaid for use in assays, screens and diagnosis
5
Pharmaceutical preparations, preparations for therapeutic, prophylactic and/or pharmacological purposes; peptides and polypeptides
9
Computer software; data processing equipment and computers; computer software and databases for the identification and characterisation of genes and proteins through bioinformatics and related techniques; computer software for drug discovery research, gene therapy and disease diagnosis; computer software being algorithms, including algorithms for analysis and data-mining of sequence databases; databases, including a database of complementary peptide sequences to all known genes in the human, bacterial, viral, animal and plant genomes; computer hardware; including the aforesaid goods provided on-line via a computer database or the Internet
35
Storing genetic information
42
Advice and consultation services in the fields of genomics, informatics, study of protein properties and knowledge management; identification and characterisation of genes and proteins through bioinformatics and related techniques, including consulancy and advisory services relating thereto; consultancy, advice and provision of information relating to drug discovery research, disease diagnosis; design, creation and provision of databases, including databases for the identification and characterisation of genes and proteins; design, creation and provision of computer software including computer software for data-mining; design, creation and development of proprietary informatics technology platforms, including the aforesaid for the location and definition of peptides ligands; use of bioinformatics and related techniques to define the core regions of molecular functionality and to enable the generation, design, development and validation of peptide ligands for existing and novel block targets; prediction and design of peptides from DNA sequence data; data-mining operations; identification of targets for therapeutic applications and design of inhibitors; design, optimisation and development of inhibitors for specific targets; design, creation and provision of informatics based programs designed to monitor and research databases and identify potential leads matched to a company discovery portfolio; obtaining and analysing genetic information; gene sequencing; laboratory research; collaboration with academic research groups, namely providing information in the fields of research, pharmaceuticals and technology; collaboration with pharmaceutical and biotechnology companies, namely providing information in the fields of research, pharmaceuticals and technology; preparation of drug discovery and development programmes; synthesis of peptides; including provision of the aforesaid services on-line from a computer database or the Internet